Financhill
Back

Ampio Pharmaceuticals Vs. NeuBase Therapeutics Industry Stock Comparison

Sell
23

AMPE
Ampio Pharmaceuticals

Last Price:
0.24
Seasonality Move:
-10.86%
Sell
21

NBSE
NeuBase Therapeutics

Last Price:
0.38
Seasonality Move:
6.81%
Sell
23
Ampio Pharmaceuticals (AMPE) is a Sell

Is Ampio Pharmaceuticals a Buy, Sell or Hold?

  • The current Ampio Pharmaceuticals [AMPE] share price is $0.22. The Score for AMPE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • AMPE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
21
NeuBase Therapeutics (NBSE) is a Sell

Is NeuBase Therapeutics a Buy, Sell or Hold?

  • The current NeuBase Therapeutics [NBSE] share price is $0.38. The Score for NBSE is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • NBSE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AMPE Stock Price Chart

What is Ampio Pharmaceuticals's stock price today?

  • The Ampio Pharmaceuticals share price today is $0.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMPE is experiencing slight buying pressure.

NBSE Stock Price Chart

What is NeuBase Therapeutics's stock price today?

  • The NeuBase Therapeutics share price today is $0.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBSE is experiencing slight buying pressure.

AMPE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 34.08 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.2 - 0.44) Sell
Bollinger Bands (100): (0.66 - 2) Sell

NBSE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 30.84 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.39 - 0.43) Sell
Bollinger Bands (100): (0.44 - 0.84) Sell

AMPE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.25 Sell
20-day SMA: 0.29 Sell
50-day SMA: 0.81 Sell
200-day SMA: 2.3 Sell
8-day EMA: 0.25 Sell
20-day EMA: 0.35 Sell
50-day EMA: 0.73 Sell
200-day EMA: 4.02 Sell

NBSE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.39 Sell
20-day SMA: 0.41 Sell
50-day SMA: 0.56 Sell
200-day SMA: 0.74 Sell
8-day EMA: 0.39 Sell
20-day EMA: 0.41 Sell
50-day EMA: 0.51 Sell
200-day EMA: 1.5 Sell

Ampio Pharmaceuticals Earnings Growth & AMPE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NeuBase Therapeutics Earnings Growth & NBSE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.28 per share, and a decrease next year of $0.50 per share.

Ampio Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NeuBase Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):